July 14, 2021

Nigeria has recorded 14,550 of mild to moderate adverse reactions to the vaccines but no fatalities linked to the shots, the National Primary Health Care Development Agency (NPHCDA) said on Tuesday at a press briefing in Abuja .

Faisal Shuaib, head of the Agency also noted that the country expects to receive nearly 8 million additional doses of COVID-19 vaccines by the end of August, including from the U.S. government.

He added that Nigeria exhausted its initial supply of nearly 4 million shots last week and aims to resume vaccinations within weeks, when the new doses arrive.

“Nigeria expects delivery of 3.924 million doses of Oxford/AstraZeneca shots from global vaccine-sharing scheme COVAX by the end of July or early August, Shuaib said, and an additional 3.93 million doses of either Pfizer/Biotech or Moderna, donated by the U.S. government via COVAX, in August”.

He said Nigeria expects another 3.577 million doses of Pfizer/Biotech or Moderna from COVAX in the third quarter, as well as 29.85 million Johnson & Johnson shots purchased via the African Union, though he did not say when these would arrive.

The White House last month outlined a plan to share 55 million U.S. COVID-19 vaccine doses globally via COVAX.